XML 91 R78.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Liabilities - 2027 Term Loan - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
May 08, 2024
Apr. 01, 2024
Feb. 05, 2024
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2022
Jan. 05, 2022
Debt Instrument [Line Items]              
Interest rate       12.60%      
Debt partial prepayment to be Made     $ 175,000        
Minimum net sales convenant level agreed to be maintained over past year     $ 125,000        
Loss on debt extinguishment         $ 12,630 $ 6,222  
Outstanding amount payoff           $ 109,000  
2027 Term Loans              
Debt Instrument [Line Items]              
Principal amount   $ 250,000          
Interest rate         0.26161%    
Spread on variable rate         1.00%    
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]         us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember    
Partial prepayment of principal   175,000          
Outstanding amount paid off   $ 181,900     $ 260,387    
2027 Term Loans | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Principal amount             $ 300,000
Funded amount             $ 250,000
Stated interest rate             8.25%
Prepayment premium percentage 3.00%            
Loss on debt extinguishment         $ 12,600    
Outstanding amount payoff $ 79,600